Tcg Crossover Management, LLC Ventyx Biosciences, Inc. Transaction History
Tcg Crossover Management, LLC
- $612 Million
- Q4 2024
A detailed history of Tcg Crossover Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 316,195 shares of VTYX stock, worth $439,511. This represents 0.11% of its overall portfolio holdings.
Number of Shares
316,195
Previous 316,195
-0.0%
Holding current value
$439,511
Previous $689,000
0.44%
% of portfolio
0.11%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding VTYX
# of Institutions
134Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$6.63 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$6.23 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$5.94 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$5.63 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$5.26 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $78.6M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...